OPPM
DCPH

Opus Point Partners Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Opus Point Partners Management’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$632K Hold
18,631
– – 1.14% 20
2019
Q2 		$420K Hold
18,631
– – 0.62% 42
2019
Q1 		$432K Buy
+18,631
New +$488K 0.59% 42

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $74.1B AUM 71.18% 1-Year Est. Return

Opus Point Partners Management's DCPH Position: Q3 2019 in Review

Opus Point Partners Management held its Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) position steady in Q3 2019 at 18,631 shares worth $632K. The position accounts for 1.14% of the portfolio, ranked #20.

Opus Point Partners Management first reported a position in DCPH in Q1 2019 and has held it in 3 quarters since. 122 funds tracked by Wall St. Rank hold DCPH as of Q3 2019.

  • Opus Point Partners Management held 18,631 shares of Deciphera Pharmaceuticals, Inc. Common Stock worth $632K as of Q3 2019.
  • Opus Point Partners Management left its Deciphera Pharmaceuticals, Inc. Common Stock share count unchanged in Q3 2019.
  • Deciphera Pharmaceuticals, Inc. Common Stock made up 1.14% of Opus Point Partners Management's portfolio in Q3 2019, its #20 holding.
  • Opus Point Partners Management first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q1 2019 and has held it in 3 quarters since.
  • 122 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q3 2019.

Based on Opus Point Partners Management's 13F filing for Q3 2019, filed 14 Nov 2019.